BIOMAT Database Logo BIOMAT Database Logo

Antihaemophilic factor A (F VIII) and serum fibrin-fibrinogen degradation products in hepatic cirrhosis. 1973

M van Outryve, and G Baele, and G A de Weerdt, and F Barbier

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D010958 Plasminogen Precursor of plasmin (FIBRINOLYSIN). It is a single-chain beta-globulin of molecular weight 80-90,000 found mostly in association with fibrinogen in plasma; plasminogen activators change it to fibrinolysin. It is used in wound debriding and has been investigated as a thrombolytic agent. Profibrinolysin,Glu-Plasminogen,Glutamic Acid 1-Plasminogen,Glutamyl Plasminogen,1-Plasminogen, Glutamic Acid,Glu Plasminogen,Glutamic Acid 1 Plasminogen,Plasminogen, Glutamyl
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D005260 Female Females
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen

Related Publications

M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
Fibrin-fibrinogen degradation products in hepatic cirrhosis.
January 1977, Acta medica Iugoslavica,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
[Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
January 1972, Sangre,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis.
January 1977, Acta haematologica,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
Fibrinogen-fibrin degradation products and factor XIII.
January 1974, Acta haematologica,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
[Serum levels of fibrinogen degradation products in patients with hepatic cirrhosis].
October 1987, Recenti progressi in medicina,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
[Clinical significance of fibrinogen/fibrin degradation products (F/F DP)].
January 1979, Vutreshni bolesti,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.
August 1971, British medical journal,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
Fibrinogen-fibrin degradation products.
January 1980, Annals of clinical and laboratory science,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
A method for characterising serum fibrinogen and fibrin degradation products.
August 1976, Thrombosis research,
M van Outryve, and G Baele, and G A de Weerdt, and F Barbier
[Fibrin and fibrinogen degradation products].
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!